semaglutide who qualifies for GLP-1 Injections for Weight Loss? A pilot program will cover

It is important for you to drink fluids to help reduce your chance of dehydration

Novo Nordisk has added ileus to the Postmarketing Experience section of the Wegovy label under Gastrointestinal Disorders. In October 2025, Severe Gastrointestinal Adverse Reactions was added to the WARNING AND PRECAUTIONS section of the label

Patient education regarding proper administration technique is crucial for optimal outcomes

In one study, off-label use was one of the top factors in adverse event reports about semaglutide

A thorough risk evaluation with your doctor is essential before starting treatment

It carries metabolic consequences